Zhou W - Search Results

1

Genotyping patients with recent blood transfusions.

Gong MN, Sai Y, Zhou W, Thompson BT, Xu LL, Christiani DC. Gong MN, et al. Among authors: zhou w. Epidemiology. 2003 Nov;14(6):744-7. doi: 10.1097/01.ede.0000091680.23304.21. Epidemiology. 2003. PMID: 14569193 Free PMC article.

2

Genetic polymorphisms in N-acetyltransferase-2 and microsomal epoxide hydrolase, cumulative cigarette smoking, and lung cancer.

Zhou W, Liu G, Thurston SW, Xu LL, Miller DP, Wain JC, Lynch TJ, Su L, Christiani DC. Zhou W, et al. Cancer Epidemiol Biomarkers Prev. 2002 Jan;11(1):15-21. Cancer Epidemiol Biomarkers Prev. 2002. PMID: 11815396

3

Gene-environment interaction for the ERCC2 polymorphisms and cumulative cigarette smoking exposure in lung cancer.

Zhou W, Liu G, Miller DP, Thurston SW, Xu LL, Wain JC, Lynch TJ, Su L, Christiani DC. Zhou W, et al. Cancer Res. 2002 Mar 1;62(5):1377-81. Cancer Res. 2002. PMID: 11888908

4

Utility of the WHO neurobehavioral core test battery in Chinese workers-a meta-analysis.

Zhou W, Liang Y, Christiani DC. Zhou W, et al. Environ Res. 2002 Feb;88(2):94-102. doi: 10.1006/enrs.2001.4322. Environ Res. 2002. PMID: 11908934

5

Counterpoint: the myeloperoxidase -463G-->a polymorphism does not decrease lung cancer susceptibility in Caucasians.

Xu LL, Liu G, Miller DP, Zhou W, Lynch TJ, Wain JC, Su L, Christiani DC. Xu LL, et al. Among authors: zhou w. Cancer Epidemiol Biomarkers Prev. 2002 Dec;11(12):1555-9. Cancer Epidemiol Biomarkers Prev. 2002. PMID: 12496043

6

No association between the p21 codon 31 serine-arginine polymorphism and lung cancer risk.

Su L, Liu G, Zhou W, Xu LL, Miller DP, Park S, Lynch TJ, Wain JC, Christiani DC. Su L, et al. Among authors: zhou w. Cancer Epidemiol Biomarkers Prev. 2003 Feb;12(2):174-5. Cancer Epidemiol Biomarkers Prev. 2003. PMID: 12582031 Clinical Trial. No abstract available.

7

Polymorphisms in the DNA repair genes XRCC1 and ERCC2, smoking, and lung cancer risk.

Zhou W, Liu G, Miller DP, Thurston SW, Xu LL, Wain JC, Lynch TJ, Su L, Christiani DC. Zhou W, et al. Cancer Epidemiol Biomarkers Prev. 2003 Apr;12(4):359-65. Cancer Epidemiol Biomarkers Prev. 2003. PMID: 12692111

8

P53 (codon 72) and P21 (codon 31) polymorphisms alter in vivo mRNA expression of p21.

Su L, Sai Y, Fan R, Thurston SW, Miller DP, Zhou W, Wain JC, Lynch TJ, Liu G, Christiani DC. Su L, et al. Among authors: zhou w. Lung Cancer. 2003 Jun;40(3):259-66. doi: 10.1016/s0169-5002(03)00081-3. Lung Cancer. 2003. PMID: 12781424

9

XPD and XRCC1 genetic polymorphisms are prognostic factors in advanced non-small-cell lung cancer patients treated with platinum chemotherapy.

Gurubhagavatula S, Liu G, Park S, Zhou W, Su L, Wain JC, Lynch TJ, Neuberg DS, Christiani DC. Gurubhagavatula S, et al. Among authors: zhou w. J Clin Oncol. 2004 Jul 1;22(13):2594-601. doi: 10.1200/JCO.2004.08.067. Epub 2004 Jun 1. J Clin Oncol. 2004. PMID: 15173214 Clinical Trial.

10

Excision repair cross-complementation group 1 polymorphism predicts overall survival in advanced non-small cell lung cancer patients treated with platinum-based chemotherapy.

Zhou W, Gurubhagavatula S, Liu G, Park S, Neuberg DS, Wain JC, Lynch TJ, Su L, Christiani DC. Zhou W, et al. Clin Cancer Res. 2004 Aug 1;10(15):4939-43. doi: 10.1158/1078-0432.CCR-04-0247. Clin Cancer Res. 2004. PMID: 15297394

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

22,784 results

Search Page

Filters